Xenon Pharmaceuticals XENE Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's cash ratio?
- Xenon Pharmaceuticals (XENE) reported cash ratio of 13.7× in Q1 2026.
- How has Xenon Pharmaceuticals's cash ratio changed year-over-year?
- Xenon Pharmaceuticals's cash ratio increased by 276.4% year-over-year, from 3.6× to 13.7×.
- What is the long-term trend for Xenon Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's cash ratio has grown at a 9.4% compound annual growth rate (CAGR), from 3× to 4.8×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.